AllDocs -> cancers

Uterine cancer The uterus (womb) is part of the female reproductive system. It is shaped like an upside down pear and sits inside the pelvis. It is in the uterus that a fertilised egg grows into a baby. Over 470 Victorian women are diagnosed with cancer of the uterus every year. Most of these women are over the age of 50 years. Cancer of the uterus is also known as cancer of the womb, uterine cancer , endometrial cancer and cancer of the lining of the womb. Different types Most cases of cancer of the uterus are cancers of the uterus lining (endometrium), though some cancers grow in the muscle layers of the uterus. The different types of uterine cancer include: • Adenocarcinoma of the endometrium - around 85 per cent of women diagnosed with cancer of the uterus have this form. An adenocarcinoma is a cancer that starts in ...

Telephone 13 11 20 for cancer information and support Cancer Uterus Cancer of the of the Uterus A GUIDE FOR WOMEN,THEIR FAMILIES AND FRIENDS A GUIDE FOR WOMEN,THEIR FAMILIES AND FRIENDS Page 2 Cancer of the uterus First published December 1997 This edition August 2004 Acknowledgments The Cancer Council thanks everyone who contributed to the development and revision of this booklet. Illustrations on pages 6, 7 and 15 by Con Stamatis. Many Cancer Council services, including the publication of this booklet, would not be possible without the generous support of many Victorians. 1 Rathdowne Street Carlton Vic 3053 Australia Cancer Helpline: 13 11 20 Telephone: (03) 9635 5000 Facsimile: (03) 9635 5270 Email: enquiries@cancervic.org.au ...

Uterine Cancer Recovery by Gladys Abeashie At the end of March 1989, after several months of noticeable decreasing strength and loss of weight, I was diagnosed by my doctor in Ghana as having uterine tumors around the cervical and fallopian areas. I had suffered menstrual difficulties and infections and was terrified by this abnormal situation. I told the gynecologist that I was psychologically upset and emotionally unstable. "Whatever you find, I want you to tell me," I insisted. He agreed and recognized that I am the kind of person who must know the score to feel in control, or at least understand the situation. He kept his word. In view of how the tumor was beginning to block the entrance from the vulva, I was in danger of starving. The doctors hoped to remove the tumor surgically, but this was not possible because it was associated with major vital organs. The surgeon/gynecologist and pathologist ...

1091 Braz J Med Biol Res 39(8) 2006 Reporting uterine cancer mortality Brazilian Journal of Medical and Biological Research (2006) 39: 1091-1099 ISSN 0100-879X The effect of performing corrections on reported uterine cancer mortality data in the city of São Paulo 1 Departamento de Odontologia Social, Faculdade de Odontologia, 2 Departamento de Epidemiologia, Faculdade de Saúde Pública, Universidade de São Paulo, São Paulo, SP, Brasil J.L.F. Antunes 1 and V. Wünsch-Filho 2 Abstract Reports of uterine cancer deaths that do not specify the subsite of the tumor threaten the quality of the epidemiologic appraisal of corpus and cervix uteri cancer mortality. The present study assessed the impact of correcting the estimated corpus and cervix uteri cancer mortality in the city of São Paulo, Brazil. The epidemiologic ...

UTERINE SARCOMA - CANCER SITES UTERINE SARCOMA What Is Cancer ? Cancer develops when cells in a part of the body begin to grow out of control. Although there are many kinds of cancer , they all start because of out-of-control growth of abnormal cells. Normal body cells grow, divide, and die in an orderly fashion. During the early years of a person's life, normal cells divide more rapidly until the person becomes an adult. After that, cells in most parts of the body divide only to replace worn-out or dying cells and to repair injuries. Because cancer cells continue to grow and divide, they are different from normal cells. Instead of dying, they outlive normal cells and continue to form new abnormal cells. Cancer cells develop because of damage to DNA. This substance is in every cell and directs all its activities. Most of the time when DNA becomes damaged the body is able to repair it. ...

© Kamla-Raj 2003 KEYWORDS Cervix smears; micronuclei; exfoliated urine cells ABSTRACT Cytogenetic damage was assessed using the (MN) test in urothelial cells and cervix smears of local cervix cancer patients since the genetic end-point screening for micronuclei provides a measure of both, chromosome breakage and loss. The MN data were grouped for stage-types of cancer , age-groups, age-at- marriage, parity levels and socio-economic status. A comparison of the results obtained from both the tissues has revealed that the percent frequency of MNd cells was elevated in urothelial cells except when the variable for age-groups of the patients was compared. If validated, the MN assay in urothelial cells may prove useful for screening programmes for cervix cancer as besides scoring effectively for cytogenetic damage, it utilizes a non-invasive process of sample collection. INTRODUCTION ...

? 50 ? Tokai J Exp Clin Med., Vol. 31, No. 2, pp. 50-54, 2006 INTRODUCTION Cancer screening has gradually become more com- mon in Japan since the 1960s. Uterine cervical cancer screening, which is performed using a cytological examination, is an excellent screening method that has been performed on a nationwide scale since 1983 as part of the health care program specified by the Health and Medical Service Law for the Aged. From 1955 to 1965, the mortality of uterine cancer ranked second after gastric cancer among site-specific cancers in females. In recent years, the prevalence rate of uterine cervical cancer has ranked second, after breast cancer , and 5,202 patients died due to this cancer in 2000. Although the mortality of uterine cervical cancer has shown a tendency to decrease over recent years, this cancer still accounts for 4.5% of deaths due ...

ENDOMETRIAL ( UTERINE ) CANCER - All Sections ENDOMETRIAL ( UTERINE ) CANCER What Is Cancer ? Cancer develops when cells in a part of the body begin to grow out of control. Although there are many kinds of cancer , they all start because of out-of-control growth of abnormal cells. Normal body cells grow, divide, and die in an orderly fashion. During the early years of a person's life, normal cells divide more rapidly until the person becomes an adult. After that, cells in most parts of the body divide only to replace worn-out or dying cells and to repair injuries. Because cancer cells continue to grow and divide, they are different from normal cells. Instead of dying, they outlive normal cells and continue to form new abnormal cells. Cancer cells develop because of damage to DNA. This substance is in every cell and directs all its activities. Most of the time when DNA becomes damaged, either ...

Page 2 Mortality trends in England; ICD9 (182), ICD10 (C54); File: Sepho 96-04 V2 Uterine cancer in England 1996 to 2004. Mortality trends Authors: Michael Goldacre, Marie Duncan, Paula Cook-Mozaffari, Matthew Davidson, Henry McGuiness, Daniel Meddings Published by: Unit of Health-Care Epidemiology, Oxford University, and South-East England Public Health Observatory, 2006 This document provides a profile of trends in mortality for uterine cancer in England. The period covered is January 1 1996 to December 31 2004. The data are analysed from mortality files supplied to the South East England Public Health Observatories (SEPHO) by the Office for National Statistics (ONS). Mortality rates were calculated for the condition certified as the underlying cause of death and for the disease certified as any mention on the death certificates. Age-specific ...

Arq Neuropsiquiatr 2006;64(2-A):300-302 D e p a rtment of Neuro s u rg e ry, Hospital Nossa Senhora das Graças, Curitiba PR, Brazil: 1 Resident in Neuro s u rg e ry; 2 N e u ro s u rg e o n ; 3 Neurosurgeon, Federal University of Sergipe (Aracaju SE, Brasil); 4 Neurosurgeon Director of the Residency Program. Received 7 June 2005, received in final form 16 January 2006. Accepted 23 January 2006. D r. Joacir Graciolli Cord e i ro - Rua Alcides Munhoz 433 - Neuro c i ru rgia - 80810-040 Curitiba PR - Brasil. E-mail: joacirg c @ h o t m a i l . c o m CEREBRAL META S TASIS OF CERVICAL UTERINE CANCER Report of three cases Joacir Graciolli Cordeiro 1 , Daniel Monte-Serrat Prevedello 2 , Léo Fernando da Silva Ditzel 2 , Carlos Umberto Pereira 3 , João Cândido Araújo ...

3 rd Annual Uterine Cancer Biology Symposium Strategies in the Management of Uterine Papillary Serous, Malignant Mullerian Tumor, and Clear Cell Carcinoma Saturday May 13, 2006 The Farrell Learning and Teaching Center, St. Louis Course Co-Chairs Russell R. Broaddus, M.D, Ph.D. Karen H. Lu, M.D. David G. Mutch, M.D. Jointly-Sponsored By Washington University School of Medicine Continuing Medical Education and M.D. Anderson Cancer Center Gynecologic Oncology Presented By Page 2 COURSE OBJECTIVES This activity is designed for gynecologic oncologists, radiation oncologists, gynecologic pathologists, medical oncologists, research scientists, nurses, fellows, residents and students. The goal of the symposium is to explore novel approaches in the prevention ...

Page 2 Cancer of the uterus in England 1996 to 2004. A geographical profile of mortality. Authors: Michael Goldacre, David Yeates, Leicester Gill, Myfanwy Griffith, Henry McGuinness, Daniel Meddings Published by: Unit of Health-Care Epidemiology, Oxford University, and South East England Public Health Observatory, 2005 This document provides a geographical profile of mortality from cancer of the uterus in England. The geographical areas covered are the standard local authority areas of England. The period covered is January 1 1996 to December 31 2004. The data are analysed from mortality files supplied to the Public Health Observatories by the Office for National Statistics. This analysis includes mortality data about females of all ages. The map, chart and table show standardised mortality ratios (SMRs). The data in the map are shown as quintiles of local authorities, ...

71 Cancer of the Uterine Cervix 12 12.1. INTRODUCTION AND SUMMARY The registration and classification of cancer of the cervix is more difficult than that of other cancers, as the majority of cancers of the cervix are very early lesions detected because of screening. Opinions differ on whether these lesions are cancerous or pre-cancerous, and on their likelihood of progressing, without treatment, to invasive cancer . The National Cancer Registry’s policy is to register all cancers of the cervix, including CIN III, regardless of type, if they have been verified by histology. However, the lesions registered as "in situ" below would not be registered as " cancer " by the majority of cancer registries and are not included in international comparisons. Invasive cancers of the cervix make up only a small proportion of female cancers (1.8%) (Table 12.1). Mortality for invasive cancers is ...

Endometrial ( Uterine ) Cancer This material is intended for insurance informational purposes only and is not personal medical advice for clients. This marketing material includes an expiration date and use of this material must be discontinued as of the expiration date. FOR INTERNAL USE ONLY. NOT FOR USE WITH THE PUBLIC ©2005 The Prudential Insurance Company of America 751 Broad Street, Newark, NJ 07102-3777 Rx060 IFS-A018915 Ed. 10/05 Exp. 04/07 Endometrial ( uterine ) cancer is diagnosed in almost 39,300 women/year in the U.S. Although cancer death rates have been declining since the 1930’s due primarily to earlier diagnosis, endometrial cancer still accounts for approximately 6,600 cancer deaths each year. It occurs most frequently in women between the ages of 50 and 70. Risk Factors for endometrial cancer inlude: o menstrual irregularities o never being pregnant ...

Page 2 Uterine cancer in England 1998/9 to 2002/3. A geographical profile of hospital admissions. Authors: Michael Goldacre, David Yeates, Leicester Gill, Henry McGuinness, Daniel Meddings Published by: Unit of Health-Care Epidemiology, Oxford University, and South East England Public Health Observatory, 2005 This document provides a geographical profile of hospital admission for cancer of the uterus (excluding cervix) in England. The geographical areas covered are the standard local authority areas of England. The period covered is April 1 1998 to March 31 2003. The data are from Hospital Episode Statistics (HES). HES includes data on all NHS hospital admissions (including admissions for day case care). This analysis includes HES data about women of all ages. The maps show: (a) The spell-based admission rates per 100,000 resident population for each ...

INTRODUCTION Uterine body cancer (UBC) composed mainly of endometrial adenocarcinoma is steadily increasing in Japan as well as in Western countries. It accounted for more than 10 % of overall uterine cancers in the 70’s, and exceeded 45 % in 2001 [1]. According to a nation-wide UBC mass screening as required by the Health and Medical Service Law for the Aged (the Law ) since 1987 [2], the number of examinees who participated in the screening for UBC and uterine cervical cancer (UCC) was 20,115 and 3,674,936 in 1987 and 332,495 and 3,825,670 in 2001, respectively [3], with the rate of UBC examinees in those of UCC being 0.5 % in 1987 and 8.7 % in 2001. Although UBC has recently become a major gynecologic malignancy in Japan, examinees for UBC mass screening are selected when gynecologists consider that the examination is necessary according ...

Phase I Study of Concurrent Chemoradiotherapy for Locally Advanced Uterine Cervical Cancer Cervical Cancer Cervical Cancer Cervical Cancer Forum for Nuclear Cooperation in Asia (FNCA) Application of Radioisotopes Application of Radioisotopes Application of Radioisotopes Application of Radioisotopes And Radiation for Medical Use Page 2 Objectives 1. Evaluate the acute toxicity of concurrent chemo Evaluate the acute toxicity of concurrent chemo Evaluate the acute toxicity of concurrent chemo Evaluate the acute toxicity of concurrent chemo -radiotherapy using two dose levels of cisplatin radiotherapy using two dose levels of cisplatin radiotherapy using two dose levels of cisplatin radiotherapy using two dose levels of cisplatin (30mg/m 2 /week or 40mg/m /week or 40mg/m /week or 40mg/m ...

Accelerated Hyperfractionated Radiotherapy for Uterine Cervix Cancer (Cervix-II) FNCA 2003 Workshop on Radiation Oncology Suzhou(Soochow)/Shanghai, China, 2003 Page 2 Characteristics of Patients Page 3 CHN IDN JPN KOR PHL THA VNM Registered Cases n=103 MYS Cases Followed (%) 7 7 (100%) 7 5 (71%) 18 18 (100%) 33 33 (100%) Cases Followed (%) 16 8 (50%) 17 11 (65%) 5 5 (100%) 0 0 Total 103 87 (84.5%) Page 4 Characteristics of Registered Patients (n=103) Age (range) Tumor Size <4cm ...

Uterine (Endometrial) Cancer Information © copyright 2005 U-M Comprehensive Cancer Center The University of Michigan Health System web site does not provide specific medical advice and does not endorse any medical or professional service obtained through information provided on this site or any links to this site. Use of the UMHS web site does not replace medical consultation with a qualified health or medical professional to meet the health and medical needs of you or others. While the content of the UMHS web site is frequently updated, medical information changes rapidly and therefore, some information may be out of date, and/or contain inaccuracies or typographical errors. Cancer of the uterus is a malignant growth of cells in the endometrium, the lining of the uterus. The uterus (womb) is the muscular organ at the top of the vagina. Babies develop in the uterus, and menstrual blood comes ...

What Should I Look For? Know what is normal for your body. If you notice changes in your body and tell the doctor, the disease may be found earlier. Finding cancer of the uterus early makes it easier to treat. You should report any of the following signs to your doctor right away: Bleeding that is not your normal period; Discharge from the vagina, especially after you have stopped having periods (menopause); Bloating or cramping in your pelvis; Unintentional weight loss or gain; A lump in your pelvis. Women who take estrogen replacement therapy should report any of the following to their doctor immediately: Bleeding or spotting after sex; Bleeding that lasts longer than 7 days; Periods that come every 21 days or less; Bleeding or staining after six months or more of no bleeding at all (menopause). What Adds to My Risk? Estrogen is a hormone ...

Kuv Yuav Ceev Faj Txog Yam Dabtsi? Paub koj lub cev kom zoo. Yog koj paub los yog mloog tau hais tias muaj qhov txawv los pauv nyob hauv koj lub cev thiab qhia koj tus kws khomob, kws khomob yuav nrhiav tau tus kabmob ntxov. Yog nrhiav tau tus kabmob kheesxws ntxov, nws yuav ua txoj kev kho tus kabmob ntawd yooj yim dua. Koj yuav tsum qhia tej yam li hauv qab no rau koj tus kws khomob sai li sai tau: Los ntshav uas tsis yog koj coj khaub ncaws; Muaj tej yam dabtsi tawm hauv koj qhov chaw mos los, tom qab uas koj tsis coj khaub ncaws lawm; Tsam los yog mob ntawm koj lub plab mog; Qhov koj hnyav nce los poob uas tsi paub yog vim dabtsi; Muaj qog nyob ib ncig ntawm koj lub plab mog. Cov poj niam uas muaj txoj kev kho hu ua estrogen replacement therapy yuav tsum qhia lawv tus kws khomob sai li sai tau yog lawv muaj tej yam li hauv qab no: Los ntshav los yog pom ntshav ...

? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? • ? ? ? ? ? ? • ? ? • ? ? ? ? ? ? ? ? ?(? ? ?)? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? • ? ? ? ? ? • ()? • ? ? ?(? ?)? • ? • ? ? ? ? • ? ? ? ? ? ? ...

Age Sex Site Diagnosis pTNM Stage 1 70 F cervix squamous cell carcinoma T1aN0M0 I 2 46 F cervix squamous cell carcinoma T1a1N0M0 IA1 3 42 F cervix microinvasive squamous cell carcinoma T1a1N0M0 IA1 4 57 F cervix squamous cell carcinoma in situ TisN0M0 0 5 33 F cervix microinvasive squamous cell carcinoma T1a1N0M0 IA1 6 35 F cervix squamous cell carcinoma in situ TisN0M0 0 7 48 F cervix microinvasive squamous cell carcinoma T1a1N0M0 IA1 8 39 F cervix microinvasive squamous cell carcinoma T1N0M0 I 9 58 F cervix microinvasive squamous cell carcinoma T1N0M0 I 10 53 F cervix squamous cell carcinoma in situ TisN0M0 ...

Center for Environmental Health Studies (617) 482-9485 44 Farnsworth Street, Boston, MA 02210 http://www.jsi.com Cervical and Uterine Cancer and Exposure to Ionizing Radiation 1 Cervical and Uterine Cancer and Exposure to Ionizing Radiation Summary: Moderate evidence has been recorded of a possible connection between cervical and uterine cancers and exposure to ionizing radiation. This evidence is based upon studies of nuclear workers and others exposed to ionizing radiation. The National Research Council’s has not determined whether the uterus is sensitive to ionizing radiation. Cervical and uterine cancers are not designated as “specified” cancers under the Energy Employees Occupational Illness Compensation Program Act. Historically, cervical cancer incidence and mortality have been low in Los Alamos County and high in Rio Arriba County among New Mexico counties. ...

Approximately 34,000 American women are diagnosed with uterine cancer each year. In most instances, the cause is unknown, but for one in 10 women with uterine cancer , an inherited predisposition may be involved. Genetic risk assessment for uterine cancer should be considered if a woman: s Has been diagnosed with uterine cancer at an early age (younger than 50) s Has been diagnosed with uterine cancer and another cancer , such as colon, ovarian, stomach or bile duct s Has a history of colon polyps before age 40 s Has family members with any of the above Of hereditary uterine cancers, approximately 50 to 70 percent are associated with the hereditary nonpolyposis colorectal cancer (HNPCC) syndrome, also known as Lynch syndrome. HNPCC is caused by the inheritance of a predisposing mutation ...

research for a cure laboratory without walls National Foundation for Cancer Research Cancer FAQs about uterine cancer Frequently Asked Questions about common cancers. Page 2 Cancer FAQs What are the risk factors for endometrial cancer ? Most of the known risk factors for endometrial cancer appear to be related to changes in the balance between estrogen and progesterone, the two main female hormones. During a woman’s childbearing years, levels of each of these hormones shift on a monthly cycle, producing changes in the thickness of the endometrium. When the menstrual cycle begins, the endometrium is very thin, consisting only of a few layers of cells. But for the first 14 days of a woman’s menstrual cycle, the ovaries produce more and more estrogen, which causes endometrial cells to proliferate (grow). This results in ...

1672 Main St. Ste. E #264 • Ramona, CA 92065 • Tel: 760.789.8928 • Fax: 760.789.8929 • Toll Free: 800.475.1955 • www.proteinbiotechnologies.com HUMAN UTERINE CERVIX CANCER TISSUE MICROARRAY Catalog Number: TMA-005 Each core represents one specimen selected and pathologically confirmed. Normal matched or unmatched uterine cervix tissue is provided for comparison to the cancer tissue. Cases : 68 Cores : 80 Diameter : 1.5 mm Thickness: 5 µm Standard IHC: Cytokeratin confirmed Layout : 8 x 10 1 2 3 4 5 6 7 8 9 10 A 1 2 3 4 5 6 7 8 9 10 B 11 12 13 14 15 16 17 18 19 20 C 21 22 23 24 25 26 27 28 29 30 ...

Age-specific Cancer Incidence in Queensland Uterine cancer Rate per 100,000 population Incidence of Uterine cancer , by Age Group among Females, Queensland, Five Year Average, 1998 to 2002 Female 0 10 20 30 40 50 60 70 80 Age group (years) 0 5 10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 85+ Note: Age-specific rates are averaged over the five years, and based on age at time of diagnosis. Only the first year of each 5-year age group is displayed on the x-axis. Uterine cancer is defined by the ICD-0-2 codes of C54 Source: Queensland Cancer Registry, Queensland Health and Queensland Cancer Fund. Generated by Epidemiology Services Unit, Queensland Health For more information: Health Status Indicators ...

Age-specific Cancer Mortality in Queensland Uterine cancer Rate per 100,000 population Mortality of Uterine cancer , by Age Group among Females, Queensland, Five Year Average, 1998 to 2002 Female 0 5 10 15 20 25 30 35 Age group (years) 0 5 10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 85+ Note: Age-specific rates are averaged over the five years, and based on age at time of diagnosis. Only the first year of each 5-year age group is displayed on the x-axis. Uterine cancer is defined by the ICD-0-2 codes of C54 Source: Queensland Cancer Registry, Queensland Health and Queensland Cancer Fund. Generated by Epidemiology Services Unit, Queensland Health For more information: Health Status Indicators for ...

Trends in Cancer Incidence by Health Zone in Queensland Uterine cancer Rate per 100,000 population Incidence of Uterine cancer among Females, by Health Zone, Queensland, 1986 to 2002 Northern Central Southern 0 3 6 9 12 15 18 21 Year 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 Note: Rates are age standardised to the Australian population as at 30 June 2001. Data are reported by place of usual residence and year of diagnosis. Uterine cancer is defined by the ICD-0-2 codes of C54 Source: Queensland Cancer Registry, Queensland Health and Queensland Cancer Fund. Generated by Epidemiology Services Unit, Queensland Health For more information: Health Status Indicators ...